Prevalence and Risk Factors for Therapy Escalation in Ulcerative Colitis in the Swiss IBD Cohort Study

Inflammatory Bowel Diseases - United States
doi 10.1097/mib.0000000000000368
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Oxford University Press (OUP)

Related search

Risk Factors for Ulcerative Colitis in Shahrekord, Iran: A Case-Control Study

International Journal of Epidemiologic Research
2019English

Risk Factors for Complications After Total Colectomy in Ulcerative Colitis.

Inflammatory Bowel Diseases
AllergyImmunologyGastroenterology
2011English

Comment On: Prospective Cohort Study of Appendicectomy for Treatment of Therapy‐refractory Ulcerative Colitis

British Journal of Surgery
Surgery
2019English

Frequency of and Risk Factors for Depression Among Participants in the Swiss HIV Cohort Study (SHCS)

PLoS ONE
Multidisciplinary
2015English

167 Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study

Gastroenterology
HepatologyGastroenterology
2016English

Dose Escalation Among Ulcerative Colitis Patients Treated With Adalimumab in Sweden

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Risk Assessment in Acute Ulcerative Colitis

English

Author Response To: Comment On: Prospective Cohort Study of Appendicectomy for Treatment of Therapy‐refractory Ulcerative Colitis

British Journal of Surgery
Surgery
2019English

Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis

New England Journal of Medicine
Medicine
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy